drug
bedaquiline fumarate
Marketedupdated 5mo agoby Janssen Therapeutics
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Dec 1, 2026
61 days
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (4)
- Mar 19, 2029compositionUS 85464282.5y
- Mar 19, 2029compositionUS 85464282.5y
- Dec 1, 2026compositionUS 749834361d
- Dec 1, 2026compositionUS 749834361d
FDA exclusivities (6)
- Jun 21, 2027M-306Method (3y)263d
- Jun 21, 2027M-306Method (3y)263d
- May 27, 2027ODE-307Orphan Drug (7y)238d
- May 27, 2027ODE-307Orphan Drug (7y)238d
- Aug 9, 2026ODE-251Orphan Drug (7y)
- Aug 9, 2026ODE*ODE*
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 3h ago
Found something off?
comments(0)
5-min edit window · permanent after that